Results
46
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
46 companies
Ascendis Pharma
Market Cap: US$10.7b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$168.17
7D
-2.2%
1Y
23.2%
Alnylam Pharmaceuticals
Market Cap: US$42.3b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$317.50
7D
-1.4%
1Y
24.6%
ALTEOGEN
Market Cap: ₩22.4t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩419,000.00
7D
12.5%
1Y
59.6%
Akeso
Market Cap: HK$98.6b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$109.80
7D
19.4%
1Y
194.4%
Exelixis
Market Cap: US$12.0b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$43.51
7D
-0.3%
1Y
96.4%
Insmed
Market Cap: US$18.4b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$96.14
7D
-1.5%
1Y
36.8%
Beijing Wantai Biological Pharmacy Enterprise
Market Cap: CN¥75.8b
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
CN¥59.93
7D
-0.4%
1Y
-8.7%
argenx
Market Cap: €28.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€464.10
7D
-2.4%
1Y
11.6%
Vertex Pharmaceuticals
Market Cap: US$118.0b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$466.36
7D
3.1%
1Y
-4.0%
Eli Lilly
Market Cap: US$693.8b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$777.66
7D
0.2%
1Y
-16.6%
BeOne Medicines
Market Cap: US$28.5b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$244.47
7D
-0.3%
1Y
69.1%
Sandoz Group
Market Cap: CHF 19.0b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 44.04
7D
2.6%
1Y
29.9%
GSK
Market Cap: UK£57.2b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£14.14
7D
0.1%
1Y
-6.4%
Illumina
Market Cap: US$15.4b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$99.27
7D
1.1%
1Y
-6.9%
AstraZeneca
Market Cap: UK£160.3b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£103.40
7D
-0.6%
1Y
-13.4%
Innovent Biologics
Market Cap: HK$140.8b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$82.35
7D
5.0%
1Y
125.0%
Daiichi Sankyo Company
Market Cap: JP¥5.9t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥3,135.00
7D
-5.5%
1Y
-46.7%
AbbVie
Market Cap: US$331.4b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$189.77
7D
-0.1%
1Y
12.9%
Galderma Group
Market Cap: CHF 29.6b
Operates as a dermatology company worldwide.
GALD
CHF 124.50
7D
7.8%
1Y
70.5%
Orion Oyj
Market Cap: €9.2b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€65.65
7D
3.4%
1Y
60.8%
Sartorius Stedim Biotech
Market Cap: €19.6b
Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
DIM
€201.40
7D
-1.0%
1Y
28.3%
Incyte
Market Cap: US$13.0b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$67.67
7D
-1.5%
1Y
11.5%
Neurocrine Biosciences
Market Cap: US$12.7b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$128.74
7D
0.6%
1Y
-10.2%
Celltrion
Market Cap: ₩38.8t
A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.
A068270
₩175,500.00
7D
9.4%
1Y
2.4%
Teva Pharmaceutical Industries
Market Cap: US$19.3b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$16.63
7D
-0.06%
1Y
5.2%
Lonza Group
Market Cap: CHF 39.2b
Supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 555.60
7D
-1.5%
1Y
10.1%
Novo Nordisk
Market Cap: DKK 2.0t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 449.95
7D
2.6%
1Y
-53.4%
Torrent Pharmaceuticals
Market Cap: ₹1.1t
Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,323.45
7D
-2.7%
1Y
13.2%
Natera
Market Cap: US$21.7b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$158.48
7D
-1.4%
1Y
44.8%
Recordati Industria Chimica e Farmaceutica
Market Cap: €11.0b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€53.55
7D
-0.9%
1Y
9.7%
Takeda Pharmaceutical
Market Cap: JP¥6.9t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥4,393.00
7D
-0.02%
1Y
3.7%
Qiagen
Market Cap: US$10.3b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$47.85
7D
-0.7%
1Y
16.1%
Viatris
Market Cap: US$10.8b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$9.26
7D
0.9%
1Y
-14.3%
Tempus AI
Market Cap: US$10.1b
Operates as a healthcare technology company.
TEM
US$58.51
7D
-1.1%
1Y
67.2%
Sino Biopharmaceutical
Market Cap: HK$96.0b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$5.37
7D
2.1%
1Y
89.8%
Roche Holding
Market Cap: CHF 206.6b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 257.70
7D
-1.2%
1Y
5.4%